Bank of Nova Scotia Buys 157,772 Shares of Cigna Group $CI

Bank of Nova Scotia lifted its stake in Cigna Group (NYSE:CI) by 46.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 500,019 shares of the health services provider’s stock after buying an additional 157,772 shares during the period. Bank of Nova Scotia owned about 0.19% of Cigna Group worth $144,130,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. boosted its position in Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after buying an additional 4,738 shares in the last quarter. Maj Invest Holding A S grew its stake in Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after buying an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC increased its holdings in shares of Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after buying an additional 7,748 shares in the last quarter. National Pension Service increased its holdings in shares of Cigna Group by 3.2% during the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after buying an additional 21,203 shares in the last quarter. Finally, SCS Capital Management LLC raised its stake in shares of Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after acquiring an additional 8,609 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Insider Activity

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CI. Piper Sandler decreased their price target on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Royal Bank Of Canada cut their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Robert W. Baird reduced their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Jefferies Financial Group increased their target price on Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Finally, Mizuho set a $325.00 target price on Cigna Group in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $267.15 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The firm has a 50 day simple moving average of $279.60 and a 200 day simple moving average of $282.82. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The firm has a market cap of $70.40 billion, a P/E ratio of 12.04, a P/E/G ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is currently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.